Mark Fleury News Today

A lack of information on drug shortages can make it difficult to identify and respond to shortages appropriately, but improving supply chain transparency and federal oversight could reduce or prevent drug shortages in the US, according to experts. Conflicting information and a lack of transparency about drug shortages can make it difficult to identify and respond to shortages appropriately, according to experts.

The FDA and some oncologists have resisted efforts to require a quick, cheap gene test that could prevent thousands of deaths from a bad reaction to a common cancer drug.

One January morning in 2021, Carol Rosen took a standard treatment for metastatic breast cancer. Three gruesome weeks later, she died in excruciating pain from the very drug meant to

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

Fluorouracil can be deadly for patients who slowly metabolize it. But U.S. doctors don't often test for those at risk.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.